Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 223

The DOI matches its Crossref record.

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease

BERG, M. VAN DEN, BOERS, G. H. J., FRANKEN, D. G., BLOM., H. J., VAN KAMP, G. J., JAKOBS, C., RAUWERDA, J. A., KLUFT, C., STEHOUWERT, C. D. A. · 1995 · European Journal of Clinical Investigation

Abstract

Hyperhomocysteinaemia, defined as an abnormally high plasma homocysteine concentration after an oral methionine load, is common in young (≤ 50 years) patients with peripheral arterial occlusive disease. It is thought to predispose to atherosclerosis by injuring the vascular endothelium. Treatment with pyridoxine and/or folic acid may lower plasma homocysteine levels. In mildly hyperhomocysteinaemic patients with peripheral arterial occlusive disease, we studied the effect of daily treatment with pyridoxine (250 mg) plus folic acid (5 mg) on homocysteine metabolism (i.e. plasma concentrations in the fasting state and after methionine loading, in 48 patients) and on endothelial function (in 18 patients). Endothelial function was estimated as the plasma concentrations of the endothelium‐derived proteins, von Willebrand factor (vWF), thrombomodulin (TM), and tissue‐type plasminogen activator (tPA). At baseline, fasting homocysteine levels were above normal in 24 of the 48 patients (50%); post‐load levels, by definition, were above normal in 100% of patients. After 12 weeks of treatment, fasting and post‐load levels were normal in 98 and 100% of patients, respectively. Endothelial function was assessed in 18 patients who completed 1 year of treatment. At baseline, median vWF (235%) and TM (57.1 ng mL‐1) levels were above normal. At follow‐up, vWF levels had decreased to 170% (P= 0.01) and TM levels had decreased to 49 ng mL‐1 (P= 0.04). tPA levels were normal at baseline and did not change. Endothelial dysfunction is present in young patients with peripheral arterial occlusive disease and hyperhomocysteinaemia. Pyridoxine plus folic acid treatment normalizes homocysteine metabolism in virtually all patients, and appears to ameliorate endothelial dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.1995.tb01545.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 223

Metadata

Authors
BERG, M. V. D., BOERS, G. H. J., FRANKEN, D. G., BLOM., H. J., VAN KAMP, G. J., JAKOBS, C., RAUWERDA, J. A., KLUFT, C., & STEHOUWERT, C. D. A.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
1995-03
Volume
25
Issue
3
Pages
176-181
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2147261497
Cited by
223
References
0
FWCI
11.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. https://app.cochat.ai/papers/10.1111/j.1365-2362.1995.tb01545.x
The paper
BERG, M. V. D., BOERS, G. H. J., FRANKEN, D. G., BLOM., H. J., VAN KAMP, G. J., JAKOBS, C., RAUWERDA, J. A., KLUFT, C., & STEHOUWERT, C. D. A. (1995). Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.1995.tb01545.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.